• ERAD-Hijacking Chimeras Enable Degradation of Membrane Prote

  2026-06-23

  Song et al. (2026) introduce ERAD-engaging chimeras (ERADECs), a new small-molecule technology that selectively degrades transmembrane proteins by hijacking the ER-associated degradation pathway. This advance overcomes longstanding challenges in targeted protein degradation and offers a robust platform for modulating membrane protein function in immunology and oncology research.

• Kanamycin Sulfate: Water-Soluble Antibiotic for Precision Re

  2026-06-23

  Kanamycin Sulfate, a high-purity water-soluble antibiotic from APExBIO, empowers microbiology and antibiotic resistance research with proven consistency and selectivity. This article unpacks experimental workflows, protocol parameters, and troubleshooting tips, highlighting how Kanamycin Sulfate underpins robust selection and mechanistic studies in modern labs.

• Spirocyclic POM Analogues Target MmpL3 in Tuberculosis Resea

  2026-06-22

  This study reports the design and biological evaluation of spirocyclic phenyl oxazole methyl (POM) analogues targeting the MmpL3 transporter in Mycobacterium tuberculosis. The research identifies a lead compound with potent activity against drug-susceptible and drug-resistant TB isolates, highlighting a new direction for anti-tubercular drug discovery.

• Dimetridazole: Enhancing Antimicrobial Assays & MDR E. coli

  2026-06-22

  Dimetridazole, a 1,2-dimethyl-5-nitroimidazole, delivers potent synergy in combination antimicrobial assays, specifically reviving cefotaxime efficacy against multidrug-resistant E. coli by targeting membrane integrity and fatty acid biosynthesis. This guide details applied workflows, protocol refinements, and troubleshooting insights—making Dimetridazole indispensable for modern infection model research and quorum sensing inhibitor studies.

• GPX4-Driven Glutathione Metabolism and Platinum Resistance i

  2026-06-21

  This study uncovers how glutathione peroxidase 4 (GPX4)-dependent high glutathione consumption underpins acquired resistance to platinum-based chemotherapy in brain metastases of lung cancer. By delineating the Wnt/NR2F2/GPX4 regulatory axis, the research provides a mechanistic basis and potential therapeutic strategies for overcoming chemoresistance in this challenging clinical context.

• Ceftazidime in Translational Research: Precision Against Res

  2026-06-20

  This article explores the pivotal role of Ceftazidime—a third-generation cephalosporin—in advancing translational research against multidrug-resistant Gram-negative bacteria. Beyond a mechanistic deep-dive, it addresses evolving resistance landscapes, experimental best practices, and actionable strategies for researchers confronting complex infection models.

• AO/PI Staining Solution: Precision Fluorescent Cell Viabilit

  2026-06-19

  The AO/PI Staining Solution leverages dual fluorescent DNA dyes for accurate live/dead cell discrimination, overcoming limitations of traditional viability assays. This article details advanced workflows, protocol optimization, and troubleshooting strategies tailored for translational research in cell injury and apoptosis, as exemplified in diabetic nephropathy models.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-06-19

  This study provides a detailed molecular epidemiology of carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. It identifies the high prevalence, genetic carriers, and rapid horizontal transfer of carbapenemase-encoding genes (CEGs), highlighting implications for antimicrobial resistance research and infection control.

• ORM2 Modulates Autophagy to Alleviate Pancreatic Fibrosis in

  2026-06-18

  This study identifies ORM2 as a key regulator of pancreatic fibrosis in chronic pancreatitis, acting through the inhibition of autophagy in pancreatic stellate cells via ZG16 binding. The findings open new therapeutic avenues for targeting fibrotic progression by modulating PSC activation and autophagic flux.

• Rotigotine Hydrochloride: Continuous Dopaminergic Modulation

  2026-06-18

  Explore the distinct continuous delivery profile and multifaceted receptor targeting of Rotigotine hydrochloride, a leading dopamine D2/D3 receptor agonist. This article reveals nuanced assay guidance and translational insights, setting it apart from workflow-focused resources.

• Estradiol in Research: Protocols, Innovations, and Troublesh

  2026-06-17

  Estradiol (17 beta-estradiol) enables precise modeling of estrogen receptor signaling and organ protection in cardiovascular and metabolic research. This article delivers protocol enhancements, cross-study insights, and practical troubleshooting strategies to maximize reproducibility and translational impact using APExBIO’s trusted Estradiol reagent.

• Hexetidine (NSC-17764): Protocols for Biofilm and Oral Infec

  2026-06-17

  Hexetidine (NSC-17764) stands out as a versatile antibacterial agent for oral infections and resilient biofilm models, offering unique advantages over classic antibiotics—especially on medical device surfaces. This guide delivers actionable protocols, data-driven troubleshooting, and strategic comparisons, empowering researchers to maximize antimicrobial efficacy with Hexetidine.

• NF 449: Defining Selectivity for P2X1 Receptors in Purinergi

  2026-06-16

  The reference study establishes NF 449 as the most potent and selective antagonist for P2X1-containing purinergic receptors, enabling precise dissection of ATP-mediated signaling. Its high specificity provides a valuable tool for platelet aggregation and antithrombotic research, setting a new standard for receptor subtype-selective inhibition.

• Ceftazidime in Gram-Negative Infection Research: Protocols &

  2026-06-16

  Ceftazidime, a third-generation cephalosporin, stands apart for its precision in Gram-negative bacterial infection research, particularly against multidrug-resistant Pseudomonas aeruginosa. This article delivers actionable workflows, workflow enhancements, and troubleshooting strategies, translating the latest resistance dynamics into improved experimental designs and outcomes.

• Haloprogin: Applied Workflows for Antifungal and Antimicrobi

  2026-06-15

  Haloprogin’s low MICs and broad-spectrum activity empower robust in vitro and in vivo studies targeting dermatophytes, Candida albicans, and Gram-positive bacteria. This guide translates core research and reference findings into actionable protocols, troubleshooting strategies, and comparative insights for advanced infectious disease experimentation.

15080 records 1/1006 page Next 12345 下5页 Last page